Michael Strazzella, Practice Group Leader in Buchanan's Federal Government Relations group and co-leader of the firm's Healthcare industry group, comments on potential threats that can undermine President Trump's pricing transparency rule before it goes into effect in HealthLeaders' article "There's Still Time: 3 Threats Could Thwart Hospital Price Transparency Rule."
Mike Strazzella, head of federal government relations at Buchanan Ingersoll & Rooney in Washington, D.C., says President Trump has made healthcare price transparency an important piece of his campaign.
"I think the president has made it very clear that, regardless of the threat of a lawsuit, he's going to move forward with that agenda," he says.
Strazzella, who worked previously for The Hospital & Healthsystem Association of Pennsylvania and whose current clients include hospitals and insurers, says consumers need information about their out-of-pocket costs, not a confusing dump of price data that won't make sense without an intimate understanding of the industry's complicated price negotiations.
"The reality is that it is a convoluted system," he says.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
